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PURPOSE. To evaluate the contribution of genetic and early life environmental factors, as
reflected by fetal anthropometric growth trajectories, toward the development of myopia
during childhood and adolescence.
METHODS. This analysis included 498 singleton Caucasian participants from the Raine
Study, a pregnancy cohort study based in Western Australia. Serial fetal biometric
measurements of these participants were collected via ultrasound scans performed at
18, 24, 28, 34, and 38 weeks’ gestation. At a 20-year follow-up, the participants under-
went a comprehensive ophthalmic examination, including cycloplegic autorefraction and
ocular biometry measurements. Using a group-based trajectory modeling approach, we
identified groups of participants with similar growth trajectories based on measurements
of fetal head circumference (HC), abdominal circumference, femur length (FL), and esti-
mated fetal weight (EFW). Differences between trajectory groups with respect to preva-
lence of myopia, axial length (AL), and corneal radius of curvature measured at the
20-year follow-up were evaluated via logistic regression and analysis of variance.
RESULTS. Prevalence of myopia was highest among participants with consistently short
or consistently long FLs (P = 0.04). There was also a trend toward increased prevalence
with larger HC in late gestation, although not at a statistically significant level. Trajectory
groups reflecting faster HC, FL, or EFW growth correlated with significantly flatter corneas
(P = 0.03, P = 0.04, and P = 0.01, respectively) and a general, but not statistically
significant, increase in AL.
CONCLUSIONS. Environmental or genetic factors influencing intrauterine skeletal growth
may concurrently affect ocular development, with effects persisting into adulthood.
Keywords: myopia, ocular biometry, fetal growth, trajectory modeling, birth cohort
Myopia arises when the eye’s refractive power is toostrong for its axial length, causing images to be focused
in front of the retina. This may be due to an elongated
axial length (AL), a short corneal radius of curvature (CR),
or a combination of these features.1 Myopic error typically
presents during school age and progresses as the eye contin-
ues to grow throughout childhood and adolescence.1 There-
fore, risk factors for myopia are likely linked to the develop-
ment of the cornea, lens, and sclera, which must be closely
coordinated to accurately correlate AL with refractive power
as the eye increases in size from the 10th week of gestation
until approximately 11 to 12 years of age.2–5 Conditions that
disrupt this coordinated process during either fetal life or
childhood may result in a refractive error.
In recent decades, the worldwide prevalence of myopia
has risen at an alarming rate, and current estimates suggest
that 50% of the global population will be myopic by the
year 2050.6 There is currently no cure for myopia, and this
condition remains a major risk factor for potentially blinding
diseases, including retinal detachment, glaucoma, macular
degeneration, and cataract formation, particularly with high
myopia (defined as ≤–6 diopters [D]).6,7 Therefore, a clear
understanding of the risk factors contributing to the devel-
opment of myopia, including those present during gestation,
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is urgently needed to determine optimal preventative strate-
gies.
Factors influencing the processes involved in prena-
tal ocular growth may be reflected in intrauterine skele-
tal growth. Indeed, neonatal anthropometry has previously
been shown to correlate with ocular morphology in both
childhood and adulthood in a number of studies; however,
the evidence for a corresponding difference in refractive
error is conflicting.8–16 Moreover, many of these studies have
used cross-sectional data only, often with a wide variation in
age at follow-up. Recently, findings from a Dutch prospec-
tive birth cohort study demonstrated an association between
fetal growth trajectories based on estimated fetal weight
(EFW) and both AL and CR at 6 years of age.17 However,
it is unknown whether this relationship persists after the
attenuation of eye growth and whether there is a corre-
sponding correlation between fetal growth trajectory and
the risk of myopic error measured in the fully grown eye.
Furthermore, there are as yet no studies that have exam-
ined individual associations of AL, CR, or myopia with gesta-
tional head circumference (HC), abdominal circumference
(AC), and femur length (FL) growth, each of which reflects
different aspects of fetal development.18
The aim of this study was to evaluate in detail the contri-
bution of genetic and early life environmental factors toward
the development of myopia during childhood and adoles-
cence, specifically by analyzing the relationships between
fetal growth trajectories based on longitudinal measure-
ments of HC, AC, FL, and EFW, as reflective of such factors,
and the risk of developing myopia by around 20 years of
age, in addition to concurrently measured ocular biometry
parameters of AL and CR.
METHODS
Study Design
The Raine Study is a prospective multigenerational epidemi-
ologic study based in Perth, Western Australia, that aims
to evaluate the contribution of early life influences toward
health outcomes in child and adult life. The original design
incorporated a randomized controlled trial to investigate the
effects of serial fetal ultrasound scans during pregnancy on
birth outcomes.19 The study enrolled 2900 pregnant women
at King Edward Memorial Hospital between 1989 and 1991.
Mothers were recruited at 16 to 18 weeks’ gestation from
the King Edward Memorial Hospital antenatal clinic and
nearby private clinics. Participating mothers (Gen1 partic-
ipants) were then randomized at a ratio of 1:1 to either
“intensive care” involving ultrasound assessment, including
fetal biometry measurements and Doppler assessment of
umbilical artery flow at 18, 24, 28, 34, and 38 weeks’ gesta-
tion, or “regular care” comprising ultrasound imaging at
18 weeks’ gestation and only as clinically indicated there-
after.19 There were 2868 live births in the original cohort,
and since birth, these offspring (Gen2 participants) have
been assessed for a wide variety of health-related outcomes
at 1, 2, 3, 5, 8, 10, 14, 17, 20, 22, 27, and 28 years of age as
a prospective cohort study.20 A comprehensive ophthalmic
examination was conducted for the first time at the Gen2-
20 year follow-up, to which all active participants were
invited.
The Raine Study is registered in the Australian New
Zealand Clinical Trials Registry.21 Written informed consent
was obtained by all Gen1 participants upon enrollment.
The protocol for ultrasound measurements was approved
by the ethics committees at King Edward Memorial Hospi-
tal, Princess Margaret Hospital, and the University of West-
ern Australia. All participants at the Gen2-20 year follow-
up provided their own informed consent, and the Human
Research Ethics Committee at the University of Western
Australia approved the protocol for ophthalmic data collec-
tion. The protocol for all data collection during gestation and
at the Gen2-20 year follow-up adhered to the Declaration of
Helsinki.
Participants
Our analysis included 498 singleton Caucasian Raine Study
Gen2 participants for whom ultrasound measurements of at
least one fetal biometric parameter were recorded around
at least four of the five nominal time points (18, 24, 28, 34,
and 38 weeks’ gestation), and refractive error measurements
were recorded at the Gen2-20 year follow-up (see Fig. 1). To
reduce the possibility of introducing a selection bias, only
participants from the “intensive care” ultrasound group were
included, since there is a higher likelihood that mothers in
the “regular care” ultrasound group with four or more ultra-
sound measurements had medical or gestational conditions
requiring them to undergo additional scans. The study popu-
lation was further restricted to Caucasian participants as only
approximately 15% of participants with sufficient ultrasound
and ophthalmic measurements for this study had parents
of non-Caucasian descent, rendering the statistical power to
examine the specific confounding effects of ethnicity in our
analysis insufficient. In addition, participants from multiple
pregnancies (i.e., twins and triplets) were excluded due to
the higher potential for pregnancy complications, including
those specific to multiple pregnancies, that may affect fetal
growth22 and that are not examined in this analysis. Where
multiple nontwin siblings were Gen2 participants, only one
randomly chosen sibling was included in the analysis to
reduce bias due to genetic similarity. Participants with any
history of ophthalmic surgery or any ophthalmic condition
known to cause a change in refractive error, such as kerato-
conus, corneal abrasions or ulcers, cataracts, or nystagmus,
were also excluded.
Data Collection
Baseline maternal characteristics were collected via ques-
tionnaires completed by Gen1 participants at 16 and
34 weeks’ gestation. Pregnancy outcomes, including medi-
cal conditions during gestation and birth parameters, were
recorded by research midwives from a review of medi-
cal records. Serial measurements of fetal HC, AC, and FL
and umbilical artery Doppler flow velocity waveforms were
obtained via ultrasound imaging by qualified sonographers
with one of two General Electric 3600 machines (Milwaukee,
WI, USA), using standard anatomical landmarks.19 EFW was
calculated using a Hadlock formula based on HC, AC, and
FL measurements.23
Techniques for ophthalmic data collection at the Gen2-
20 year follow-up have previously been described in detail
by Yazar et al.24 In brief, AL and CR were measured
using an IOLMaster V.5 (Carl Zeiss Meditec AG, Jena,
Germany). Autorefraction was performed with a Nidek
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FIGURE 1. Study population flowchart. “Sufficient numbers of ultrasound measurements” was defined as least one fetal biometric parameter
measured around at least four of the nominal time points during gestation. “Sufficient measurements” of a specific fetal growth parameter
for inclusion in the corresponding trajectory model was defined as measurements of that fetal growth parameter around at least four of the
nominal time points during gestation. The one participant removed on the basis of ophthalmic history was specifically excluded due to a
history of keratoconus.
ARK-510A (NIDEK Co. Ltd., Gamagori, Japan) both before
and after the administration of cycloplegic eye drops (one
drop tropicamide 1%, one drop phenylephrine 10%). For
this study, all analyses of the ophthalmic outcomes were
performed using measurements of the right eye only. Refrac-
tive error was calculated as the mean spherical equivalent,
that is, the sum of the spherical error and half the cylindrical
error, based on the postcycloplegic measurements. Myopia
was defined as a mean spherical equivalent of ≤−0.5 D.
A camera system developed by Ooi et al.25,26 was used to
perform measurements of the total area of conjunctival ultra-
violet autofluorescence (CUVAF) across both eyes, which
is an objective marker of an individual’s sun exposure.27
Data relating to education level and parental myopia were
collected via questionnaires. In this analysis, education level
was defined based on completion of year 12 in Australia or
equivalent (International Standard Classification of Educa-
tion Level 3).28
Statistical Analyses
We constructed trajectory models for each fetal growth
parameter as follows, using data from all participants in
our study population with ultrasound measurements of the
parameter recorded around at least four of the five nomi-
nal time points previously listed. First, a standard deviation
score (SDS) associated with each fetal biometry measure-
ment was calculated. This was performed by constructing
a linear mixed-effects model to examine the relationship
between the fetal growth parameter and gestational age
(linear and quadratic terms). Maternal height, maternal age,
and fetal sex were included as fixed effects in the model,
in view of the known influences of these three baseline
characteristics on fetal growth.18 Random effects for gesta-
tional age (intercept and slope) were also fitted to account
for individual variation about the mean. The fetal growth
parameter being examined was transformed prior to model
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construction to satisfy the model assumption of constant
variance in the residuals (square root transformations for
HC and FL and logarithmic transformations for AC and EFW).
Continuous covariates (gestational age, maternal height, and
maternal age) were centered to ensure model convergence.
For each fetal growth parameter, the associations with all
covariates in the corresponding linear mixed-effects model
were significant (P < 0.05), except those between HC and
maternal age (P = 0.06), AC and fetal sex (P = 0.15), AC
and maternal height (P = 0.16), and EFW and fetal sex (P
= 0.41); nonetheless, all covariates were retained in all four
models for consistency. The marginal residuals from each
model (i.e., the residuals calculated from predicted values
based on the fixed effects) were then standardized to create
SDSs corresponding to each fetal biometry measurement.
We used a group-based trajectory modeling (GBTM)
approach to compute trajectory models based on the SDSs.
Developed by Nagin,29 GBTM is a method designed to iden-
tify clusters (or “groups”) of individuals with similar devel-
opmental trajectories, that is, similar patterns of evolution
over time with respect to a longitudinally measured vari-
able. Each individual is then assigned to a group accord-
ing to probability of membership. Unlike similar trajectory
modeling techniques such as latent-curve modeling, GBTM
allows clusters to naturally emerge from the data even when
they are not necessarily identifiable on the basis of known
individual traits or exposures.29 Although fetal growth trajec-
tory may be influenced by feto-maternal characteristics that
are known ex ante, these characteristics are not necessarily
associated with clearly distinguishable trajectories, and as
such, GBTM was considered the most appropriate technique
for this study. For each fetal growth parameter, we deter-
mined the optimal trajectory model for analysis as follows, in
accordance with procedures outlined by Nagin29 and Nagin
and Odgers.30 We computed trajectory models of 1 to 10
SDS trajectory groups with either linear-shaped trajectory
groups or quadratic-shaped trajectory groups. Models with
different numbers of groups were compared in a stepwise
manner, and we also compared each linear trajectory model
to the quadratic trajectory model with the same number of
groups. The optimal model for each fetal growth parame-
ter was selected based on the interpretability of the group-
ing and the differences in the Bayesian information criterion
(BIC) values between the models, with a higher BIC signi-
fying a better model fit. We also required each model group
to contain a minimum of 5% of the population included in
the model and to have an average posterior probability of
more than 70%.
Trajectory groups in the selected models were compared
with respect to maternal and pregnancy characteristics,
known risk factors for myopia, and the ophthalmic
outcomes. The significance of any differences was evaluated
using logistic regression for categorical variables and anal-
ysis of variance for continuous variables or Kruskal-Wallis
tests for nonparametric continuous variables. The mater-
nal and pregnancy characteristics examined included base-
line maternal age, height, prepregnancy weight and parity,
rate of gestational weight gain, fetal sex, and the gesta-
tional conditions or exposures of hypertension in pregnancy
(including superimposed preeclampsia), diabetes (preexist-
ing or gestational), gestational anemia, smoking during preg-
nancy, and abnormal Doppler flow. There were insufficient
numbers of mothers with gestational diabetes or preeclamp-
sia to evaluate the differences between trajectory groups
with respect to these conditions alone. The known risk
factors for myopia that were compared across trajectory
groups were gestational age at birth, birth weight adjusted
for gestational age, parental myopia (categorized as neither,
one, or both parents), and total area of CUVAF and educa-
tional level recorded at the Gen2-20 year follow-up. Where
any of parental myopia, total area of CUVAF, or educational
level was found to be significantly correlated with group
membership in a trajectory model, the analyses for associ-
ations between group membership in that model and the
ophthalmic outcomes were adjusted for that specific risk
factor for myopia. Adjustments were not made for gestational
age at birth or birth weight, even if these correlated with
group membership in a trajectory model, to avoid distort-
ing the effects of these variables in the analysis due to the
fact that these variables, like trajectory group membership,
are also markers of fetal growth. The computation of group-
based trajectory models was performed using the procedure
Proc Traj within SAS statistical software, version 9.4 (SAS
Institute, Inc., Cary, NC, USA).31 All other analyses were
completed using R statistical software, version 1.1.456 (R
Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Fetal Growth Trajectories: Descriptive Results
Of the 498 Gen2 participants included in this study, suffi-
cient measurements for inclusion in the HC, AC, FL, and
EFW trajectory models were recorded for 439, 490, 496,
and 429 participants, respectively. For each of the four fetal
growth parameters, there was successive improvement in
the goodness of fit of the linear trajectory models with
increasing numbers of groups according to the BIC, until
the six-group HC model, eight-group AC model, five-group
FL model, and eight-group EFW model were reached. There-
after, the BIC decreased with increasing numbers of groups,
suggesting poorer fit. However, to ensure a proportion of
at least 5% of the population in each group, the five-group
HC model, four-group AC model, five-group FL model, and
six-group EFW model were selected for further analysis.
Each of these models also demonstrated average posterior
probabilities of more than 70% associated with all trajec-
tory groups. Models with quadratic-shaped trajectory groups
showed poorer model fit according to the BIC compared
with the linear trajectory models and so were not retained.
Plots of the trajectory groups of the four selected models
are displayed in Figure 2. The individual profiles of three
randomly chosen subjects from each trajectory group in the
HC, AC, FL, and EFW models are shown in Supplemen-
tary Figures S1, S2, S3 and S4, respectively, as an illustra-
tion of the in-group variabilities in trajectories. The selected
HC and FL models showed four relatively stable trajectory
groups reflecting participants who were consistently “small”,
“medium”, “big”, and “large” throughout gestation with
respect to the specific growth parameter. There were three
stable trajectory groups in the AC model (“small”, “medium”,
and “large”) and only two in the EFW model (“small” and
“large”). All three of the HC, AC, and FL models also
included an “accelerated” trajectory group. These groups
reflected fetuses whose growth rate increased throughout
gestation, relative to the general study population. The EFW
model showed no clear stable medium-sized group: all four
medium-sized groups showed moderate amounts of either
deceleration (the “medium-small” and “big-medium” groups)
or acceleration (the “medium-big” and “big-large” groups).
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FIGURE 2. Plots of the trajectory groups (estimated mean trajectories with 95% confidence intervals). (A) The five-group head circumference
trajectory model (n = 439). (B) The four-group abdominal circumference trajectory model (n = 490). (C) The five-group femur length
trajectory model (n = 496). (D) The six-group estimated fetal weight trajectory model (n = 429).
Supplementary Table S1 displays the maternal and preg-
nancy characteristics of participants in each model group.
Distributions of maternal age, height, prepregnancy weight,
rate of gestational weight gain, and parity and fetal sex were
generally consistent across model groups, aside from in the
FL model, which showed increased maternal prepregnancy
weight and rate of gestational weight gain in the “acceler-
ated” and “large” groups compared with the other trajec-
tory groups. With regard to gestational medical conditions,
the prevalence of hypertension in pregnancy was high-
est among individuals in the “accelerated” and “large” HC
groups and the “small” FL group. Both diabetes (preexisting
or gestational) and gestational anemia were most prevalent
in either the “large” or “accelerated” group of the HC, AC,
and EFW models, while abnormal Doppler flow occurred
most often in the “small” or “medium” HC, AC, and EFW
groups. Smoking during pregnancy was consistently associ-
ated with slower fetal growth, being most prevalent in the
“small” or “medium” groups of every model.
The distributions of known risk factors for myopia are
displayed in Supplementary Table S2. Gestational age at
birth was lowest in the “large” HC group but otherwise
did not vary substantially across trajectory groups in the
other models. Birth weight adjusted for gestational age was
considerably larger in groups representing faster growth
with respect to all fetal growth parameters (P < 0.01 in all
trajectory models). Total area of CUVAF and education level
at 20 years of age were generally consistent across trajec-
tory groups. The proportion of participants with either at
least one parent with myopia was greatest in the “large”
groups of all four models, and this difference reached statis-
tical significance in the AC model (P < 0.01). Analyses for
associations between AC trajectory group membership and
the ophthalmic outcomes, reported below, were therefore
performed both with and without adjustment for parental
myopia.
Relationship of Fetal Growth Trajectories to
Ophthalmic Outcomes
The ophthalmic characteristics of participants by trajectory
model group are presented in Figure 3 and Supplemen-
tary Table S3. A total of 98 participants (19.7% of the study
population) were myopic. The prevalence of myopia varied
between trajectory groups and was associated with group
membership in the FL model at a statistically significant level
(P = 0.04). A U-shaped trend was shown in this model, in
which the “small” and “large” groups had the highest rates
of myopia (26.5% and 29.3%, respectively) while lower rates
of myopia were found in the “medium”, “big”, and “accel-
erated” groups, which all contained participants with more
moderate FLs in later gestation. In contrast, the HC model
showed a trend of increasing prevalence of myopia with
larger HC in late gestation, although this relationship did not
reach a statistically significant level (P = 0.90). More specif-
ically, the “small” trajectory group was associated with a
markedly lower prevalence of myopia than the other groups
(13.8%), while the trajectory group with the highest preva-
lence was the “large” group, followed by the “accelerated”
group (23.3% and 21.7%, respectively). The prevalence of
myopia was generally consistent across the AC trajectory
model groups, with no significant correlation identified with
or without adjustment for parental myopia (P = 0.97 and P
= 0.77, respectively). The EFW model did not show a similar
pattern to any of the other models with respect to myopia:
the “small” and “large” groups had the lowest prevalence
(11.8% and 15.6%, respectively) compared with the other
four groups, which all had similar rates of myopia to each
other. As EFW was calculated based on HC, AC, and FL,
this pattern may reflect an offset between the relationships
demonstrated in each of the three models described above.
The mean (standard deviation) AL and CR for the study
population were 23.57 (0.89) mm and 7.75 (0.26) mm,
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FIGURE 3. Ophthalmic characteristics of participants in the trajectory groups of each model. (A) Head circumference model. (B) Abdominal
circumference model. (C) Femur length model. (D) Estimated fetal weight model. Each panel presents the prevalence of myopia (top), mean
axial length (middle), and corneal radius of curvature (bottom) for each model group. Bars represent 95% confidence intervals calculated in
a one-way analysis of variance. For myopia, P < 0.05 in the femur length model and P > 0.05 in all other models; for axial length, P > 0.05
in all models; and for corneal radius of curvature, P > 0.05 in the abdominal circumference model and P < 0.05 in all other models.
respectively. There was a clear trend in the distributions
of these ocular biometry parameters among the groups
in each model. The HC model showed a general increase
in mean AL and mean CR for groups with larger HC in
late gestation (the “big”, “accelerated”, and “large” groups)
compared with groups with smaller HC in late gestation
(the “small” and “medium” groups). Likewise, larger fetal
size in late gestation correlated with increasing AL and CR
in the EFW model, in which the longest eyes and flattest
corneas were seen in the “big-large” and “large” groups,
while the “small” and “medium-small” groups showed the
shortest mean AL and mean CR. Interestingly, although
the FL model showed a similar trend with respect to CR,
and the shortest and longest mean ALs were found in the
“small” and “large” groups, respectively, of the other three
groups, the “medium” group had both the longest mean
AL and mean CR. This may account for the relatively high
prevalence of myopia in this group compared with the
two other groups containing participants with moderate-
sized FLs in late gestation (“big” and “accelerated”). The
only associations to reach statistical significance were those
between CR and group membership in the HC, FL, and
EFW models (P = 0.03, P = 0.04 and P = 0.01, respec-
tively). The AC model also showed a shorter mean CR in
the “small” group but no clear trend in the AL distribu-
tions between the model groups or statistically significant
differences between the model groups with respect to either
AL or CR (P = 0.79 and P = 0.13, respectively), including
when adjusted for parental myopia (P = 0.71 and P = 0.37,
respectively).
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DISCUSSION
This analysis aimed to investigate possible associations
between fetal growth trajectories and myopia, AL, and CR
measured in a cohort of Caucasian adults aged around
20 years. As distinct from previous similar studies, we
analyzed fetal growth trajectories based on measurements
made during gestation of the individual growth parameters
HC, AC, and FL, in addition to a summary growth param-
eter EFW, rather than EFW alone. The most notable find-
ing was the existence of trends suggesting a close associa-
tion between myopia and intrauterine skeletal development,
particularly as reflected by FL growth trajectory. Specifi-
cally, the results showed a statistically significant U-shaped
association between FL growth trajectory and prevalence of
myopia as well as a trend toward an increased prevalence of
myopia with larger HC in late gestation that did not reach
statistical significance.
The observed trend toward increased prevalence of
myopia with larger HC in late gestation, although not statis-
tically significant, suggests that fetal HC development may
play a small role in the development of refractive error. If so,
this trend could be interpreted in terms of the effect of HC
growth on ocular biometry. A 2019 analysis from within the
Generation R Study,17 which is the other published investi-
gation to have analyzed the association between fetal growth
trajectory and ocular biometry in early childhood using fetal
biometric measurements performed during gestation rather
than postnatal surrogate markers, demonstrated an increase
in AL and decrease in CR in 6-year-olds with increasing
rate of fetal growth. In this case, fetal growth trajectory
was summarized by a change in an EFW SDS from second
trimester to birth. These results are broadly consistent with
our findings of an increase in mean AL and mean CR for
groups with larger HC in late gestation, as well as similar
relationships observed in the EFW and FL models, which
likely reflect the close correlation that exists between these
three fetal growth parameters.32
However, the fact that in our study, the associations
between HC trajectory group membership and AL did not
reach statistical significance suggests that by 20 years of age,
the relationship between HC growth trajectory and AL has
likely been diminished by the influence of environmental
risk factors for myopia introduced during childhood, such as
reduced time spent outdoors or increased time spent doing
near work. In contrast, it seems that the proportional rela-
tionship between HC growth trajectory and CR that devel-
ops during fetal life remains stable into adolescence and
adulthood. These observations are consistent with existing
studies that indicate while axial elongation can continue
into late adolescence, flattening of the cornea predominantly
takes place during infancy as a largely passive component
of emmetropization, the coordinated scaling process that
occurs from birth to 12 to 18 months in order to achieve
optimal refraction.33–36 Therefore, after this period, further
compensatory changes in corneal shape cannot occur in the
case of excessive axial elongation. In fact, several cross-
sectional studies have found that while AL and CR are
strongly correlated in emmetropes, a much weaker rela-
tionship exists between these two parameters in those with
myopia and in whom, therefore, emmetropization has been
disrupted.34,37
Investigations with larger study populations are required
to establish whether the trend toward a higher prevalence
of myopia in groups reflecting faster fetal HC growth in
this analysis was merely a chance finding or does indeed
reflect a true relationship between these two variables.
Regardless, the lack of a statistically significant association
between myopia and trajectory group membership in the
HC model indicates a high likelihood that if any additional
risk of myopia is indeed conferred by faster HC growth,
it is modified considerably by more important environ-
mental risk factors for myopia present during childhood
and adolescence. In the case that a relationship does exist,
several potential underlying mechanisms could be further
explored. It can be noted that existing studies into the rela-
tionship between orbital volume and ocular growth have
shown conflicting results and involved analyses of small
study populations.38–40 Further research involving larger
sample sizes is therefore warranted to understand whether
the observed trends in our HC model may be linked to
differences in the size of the orbital cavity and, correspond-
ingly, the available space for ocular expansion in the axial
direction. Alternatively, it is possible that the presence of
an environmental exposure or genetic predisposition, or a
combination of these factors, may render individuals more
prone to both faster fetal skeletal growth and excessive
axial elongation during childhood. Indeed, in our analysis,
higher proportions of participants with at least one parent
with myopia, and therefore a genetic predisposition toward
myopia, were determined in groups representing faster fetal
growth across all four trajectory models, most prominently
in the AC model. It can be noted that among the many genes
conferring susceptibility to myopia identified in genome-
wide association studies, several are involved in extracellular
matrix organization both within the eye and in the muscu-
loskeletal system.41–43 Subtle variations in the expression of
such genes could partially explain the patterns observed in
our results.
The U-shaped trend seen in the FL model with respect to
myopia may in part be attributable to a confounding relation-
ship between HC and FL growth. As previously stated, these
two parameters are both markers of skeletal growth and
tend to be very closely correlated during early life.32 Indeed,
while only 56.5% of the study population was allocated to
the “big”, “accelerated”, or “large” HC group, participants
from these groups represented 82.0% of participants in the
“large” FL group. The relatively high prevalence of myopia
found in the “large” FL group may therefore reflect the fact
that these participants were more likely to be members of
these three HC groups, which each had a relatively high
prevalence of myopia. However, this does not account for
the high prevalence of myopia also observed in the “small”
and “medium” FL groups. Indeed, U-shaped relationships
in disease epidemiology often represent the influence of
different processes occurring at either end of a spectrum,
resulting in the disruption of normal biological develop-
ment and function at both ends.44–46 Therefore, it is likely
that the increased prevalence of myopia in the “small” and
“medium” groups reflects a different set of genetic or envi-
ronmental factors that slowed the intrauterine FL growth of
these participants and concurrently disrupted the coordina-
tion between AL and CR during ocular development. One
potential such example could be hypertension in pregnancy:
our finding that this condition was more prevalent in the
“small” FL group compared with the other trajectory groups
in our analysis is consistent with existing research that has
demonstrated an association between pregnancy-induced
hypertension, especially preeclampsia, and fetal growth
restriction, including shorter FL.47,48
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It can be noted that the association between fetal FL
growth trajectory and the development of myopia is statisti-
cally significant, indicating that this relationship is not appre-
ciably modified by processes affecting refractive error that
take place in response to environmental stimuli present
during school-age years. It is acknowledged, however, that
the proposed mechanistic explanations are merely specula-
tive. Since both fetal growth and the development of myopia
involve a complex interplay of genetic and environmental
influences, more detailed investigation is required to elab-
orate the specific pathophysiology underlying the observed
trends and to quantify the relative extent to which differ-
ent risk factors contribute toward refractive error in young
adults, which was not formally assessed in this study.
The main strengths of our study are its prospective design
and the unique longitudinal data set containing both serial
fetal biometry measurements performed during gestation
and measurements of ophthalmic outcomes in early adult-
hood, with a narrow age range for follow-up. Much of the
existing research into early life influences on the devel-
opment of myopia has been based on cross-sectional data
and has focused on postnatal surrogate markers for fetal
growth, including birth weight, length, and HC. Prior stud-
ies have found no consistent relationship between these
neonatal biometric parameters and refractive error measured
at less than 10 years of age, despite statistically significant
correlations between these parameters and AL and CR.11–14
In contrast, modest but statistically significant associations
between birth weight and refractive error measured in adult-
hood have been found in analyses from the 1958 British
birth cohort10 and the Gutenberg Health Study,15 which both
suggest that individuals with lower birth weight for gesta-
tional age have an increased risk of developing myopia.
These results are supported by a recent UK study16 that
used a Mendelian randomization study design to determine
the causal influence of birth weight on refractive error in a
population of 37- to 73-year-old UK Biobank participants.
The effect in this study was estimated to be +0.28 D (95%
confidence interval, 0.05–0.52, P = 0.02) per standard devi-
ation increase in birth weight when adjusted for age and
gender. The apparent discrepancy between the results from
studies in adult and child populations may be accounted for
by the fact that the typical age of onset for myopia is between
9 and 12 years.49 The possibility of study participants devel-
oping myopia subsequent to completion of follow-up there-
fore does not apply to the three latter studies or to our anal-
ysis, since follow-up in these studies was conducted after
all participants had reached adulthood. The fact that the
patterns observed in the EFW model with respect to myopia
in our analysis do not appear to align with the associations
between birth weight and refractive error measured in adult-
hood demonstrated in previous studies may reflect a differ-
ence between the characterization of fetal growth via either
trajectory modeling or birth weight, the latter of which has
been shown to be unreliable as a surrogate marker for fetal
growth.50
Our study was primarily limited by its modest sample
size, which resulted in some groups, particularly those repre-
senting either accelerating growth trajectories or consis-
tently small or large fetal size, containing very small numbers
of participants. Furthermore, none of the HC, AC, or FL
models included groups representing participants whose
growth rate decelerated throughout gestation relative to the
rest of the study population, and so we were unable to
fully assess the effects of intrauterine growth restriction with
respect to these parameters. It is likely that the relatively
small sample size resulted in a very small number of partic-
ipants with decelerated growth. GBTM is known to have
poor efficacy in detecting subgroups representing only a
small proportion of a study population,51,52 and therefore
it is probable that the participants with decelerated growth
were not identified as a separate trajectory group in the anal-
ysis. Further investigation involving larger study populations
will be needed to confirm the reliability and validity of our
observed results.
The Gen2-20 year follow-up was the first time a compre-
hensive ophthalmic examination was conducted on the
Gen2 of the Raine Study, and so our study is also limited
by the lack of ophthalmic data from earlier ages. Serial
ophthalmic assessments across different ages in future birth
cohorts may strengthen the evidence for the associations
identified in this study and provide a further understand-
ing of how fetal development may influence the growth
of the eye through childhood and adolescence. Moreover,
despite the unique nature of our data set in containing a
wide range of variables relevant to fetal growth during preg-
nancy and myopia in young adulthood, it should be noted
that data related to the variables of parental myopia, total
area of CUVAF, and education status were recorded for only
just under 80% of the study population. Analyses within this
study that include these variables may therefore be subject
to bias associated with these missing data.
In addition, given the ethnic homogeneity of the study
population, the results of our analysis are exclusively appli-
cable to Caucasian populations. The risk of developing
myopia is known to vary considerably with ethnicity: for
example, a 2016 meta-analysis53 determined that the preva-
lence of myopia was 40% in 15-year-olds of either South
Asian or Southeast Asian heritage living in Australia in
contrast to a prevalence of just 17% among 15-year-olds of
Caucasian descent. Similarly, trajectories of fetal biometry
measures are significantly influenced by ethnicity.54 Inclu-
sion of larger proportions of individuals of non-Caucasian
heritage in cohorts for future investigations will be necessary
to establish whether similar associations to those observed
in this study exist in other ethnic groups.
In conclusion, our results show that specific aspects of
intrauterine skeletal growth correlate with the risk of myopia
and alterations in ocular biometry.We hypothesize that these
observations reflect processes that concurrently influence
skeletal growth in utero as well as the coordination between
axial elongation and corneal flattening during eye develop-
ment, with effects that persist into adulthood, albeit with
modification by environmental factors present during child-
hood and adolescence. Our findings provide a basis for
further investigating both genetic and intrauterine environ-
mental factors underlying the observed associations. This
research may also lead to methods for identifying infants
at risk of developing myopia as early as 38 weeks’ gesta-
tion and for implementing proven preventative strategies
for these individuals, for example, increased time spent
outdoors.
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